• Room 02.003 - PGJCCR

    United Kingdom

Accepting PhD Students

1986 …2024

Research activity per year

Personal profile

Research Interests

Kevin Prise is Professor of Radiation Biology, at the Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, where he has been since 2007. Prior to this, he was Head of the Cell and Molecular Radiation Biology Group at the Gray Cancer Institute in Northwood, London. A Biochemistry graduate of Aberdeen University, he received his PhD in Cell Biology and Biochemistry, from the University of Aberdeen, on the mechanisms of action of the chemotherapeutic methotrexate. He joined the Gray Laboratory in 1985 working with Barry Michael, Melvyn Folkard and Boris Vojnovic, under the directorships of Jack Fowler, Julie Denekamp and Ged Adams. In 2007 he was recruited by Professor Paddy Johnston to setup a Translational Radiation Biology program at the newly opened Centre for Cancer Research and Cell Biology at Queen's University Belfast. He served as Deputy Director of the Centre from 2010 to 2018 under the directorships of Professor Dennis McCancer and then Professor David Waugh.

He has developed wide-ranging interests in radiation biology including research on low dose radiation risk, radiation quality, cell and tissue signalling mechanisms. He has played a major role in the application of microbeam technologies for delineating the response of cells to targeted single tracks of radiation. His seminal work defined the impact of bystander signalling after targeted irradiation and its implications for future advanced radiotherapy where immune signalling and abscopal responses have significant potential. At Queen’s he developed an Advanced Radiotherapy Group (ARG) integrating Radiation Oncology, under the leadership of Professor Joe O’Sullivan, and Clinical Radiotherapy Physics, under the leadership of Professor Alan Hounsell, with translational radiation biology.  Together they are developing new biological based models for optimising advanced radiotherapies such as Intensity Modulated Radiotherapy and particle therapies. A current focus is the application of radionuclide approaches in advanced prostate cancer.

He is a Past-President of the US Radiation Research Society, a previous RRS Michael Fry award recipient and Friedrich Dessauer awardee of the German Radiation Research Societies. He was the 2024 recipient of the Weiss Medal from the UK Association for Radiation Research, the 2018 Douglas Lea Lecturer, awarded by the Institute of Physics and Engineering in Medicine and the 2018 Bacq and Alexander awardee from the European Radiation Research Society. He has recently served on the UK Government Expert Committee on Medical Aspects of Radiation in the Environment (COMARE) and previously Editor in Chief (Scientific) of the British Journal of Radiology.  He has supervised over 50 PhD students and numerous Masters and undergraduate students. He has taught on the FRCR Part 1 course at the Christie Hospital for the last 15 years and also launched this course internationally with Prof Catharine West in Kolkata, India in 2015 and Kuala Lumpur, Malaysia in 2017. He is a previous Part 1 examiner for the Royal College of Radiologists and a current Honorary Member. He has published over 380 papers (h=68), with over 15,000 citations.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Dive into the research topics where Kevin Prise is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or